Transcatheter closure using an Amplatzer VSD device offers an alternative to reoperation for critically ill patients with recurrent postmyocardial infarction ventricular septal defects.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for transcatheter closure in recurrent post-MI VSD.
The initial therapy for postmyocardial infarction ventricular septal defects is surgical repair of the defect. Unfortunately, a significant number of patients develop recurrent ventricular septal defects (VSDs) following operative repair. Transcatheter closure offers an alternative to reoperation in these critically ill patients. We present a series of four patients in whom recurrent ventricular septal defects were closed using an Amplatzer VSD device.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: